aiqbench analysis
This research introduces R-GEAN, a novel machine learning framework designed to predict specific medication additions and removals within hospital admissions using only the first 24 hours of data. By employing an asymmetric candidate-scoring network, the model outperforms existing baselines in identifying regimen changes without relying on leakage from complete discharge records. The study highlights critical distinctions between evaluating full treatment regimens versus detecting actual prescribing actions, offering a more rigorous benchmark for clinical AI applications.
R-GEAN: Regimen-Guided Edit Action Network for Within-Admission Medication Change Prediction
arXiv:2609.22959v1 Announce Type: cross Abstract: The medications prescribed to a patient often change during a hospital admission as clinicians start, stop, or continue therapies. We study whether models can predict which medication classes are added or removed between 24 hours after admission and discharge. Metrics that compare the complete discharge regimen can reward models for copying medications that remain unchanged, even when they identify no actual changes. We therefore introduce a leakage-controlled benchmark that predicts net ATC3 additions and removals using only prior completed admissions and information available within the first 24 hours of the current admission. Addition candidates are classes not active at 24 hours, whereas removal candidates are classes active at that time. We also introduce R-GEAN, an asymmetric candidate-scoring network with independent addition and removal predictors. Across 240,480 admissions from 82,286 patients, R-GEAN achieves the highest predefined summary of addition, removal, changed-regimen, and action-pattern performance, termed the edit composite (0.464), compared with 0.435 for the strongest primary comparator. Reimplemented RETAIN, GAMENet, and MICRON baselines obtain 0.428, 0.420, and 0.288, respectively. R-GEAN's advantage is concentrated in correctly identifying medication classes no longer active at discharge, while rare additions and admissions with multiple medication changes remain difficult. Rankings based on micro-F1 over the reconstructed discharge regimen and the edit composite correlate weakly across the evaluated models (Spearman r = 0.20). The continuation baseline achieves the highest complete-regimen score despite predicting no additions or removals. These results show that complete-regimen and edit-level evaluation measure different aspects of medication prediction. The benchmark evaluates observed prescribing changes, not treatment appropriateness
Abstract:The medications prescribed to a patient often change during a hospital admission as clinicians start, stop, or continue therapies. We study whether models can predict which medication classes are added or removed between 24 hours after admission and discharge. Metrics that compare the complete discharge regimen can reward models for copying medications that remain unchanged, even when they identify no actual changes. We therefore introduce a leakage-controlled benchmark that predicts net ATC3 additions and removals using only prior completed admissions and information available within the first 24 hours of the current admission. Addition candidates are classes not active at 24 hours, whereas removal candidates are classes active at that time. We also introduce R-GEAN, an asymmetric candidate-scoring network with independent addition and removal predictors. Across 240,480 admissions from 82,286 patients, R-GEAN achieves the highest predefined summary of addition, removal, changed-regimen, and action-pattern performance, termed the edit composite (0.464), compared with 0.435 for the strongest primary comparator. Reimplemented RETAIN, GAMENet, and MICRON baselines obtain 0.428, 0.420, and 0.288, respectively. R-GEAN's advantage is concentrated in correctly identifying medication classes no longer active at discharge, while rare additions and admissions with multiple medication changes remain difficult. Rankings based on micro-F1 over the reconstructed discharge regimen and the edit composite correlate weakly across the evaluated models (Spearman r = 0.20). The continuation baseline achieves the highest complete-regimen score despite predicting no additions or removals. These results show that complete-regimen and edit-level evaluation measure different aspects of medication prediction. The benchmark evaluates observed prescribing changes, not treatment appropriateness
Artificial Intelligence (cs.AI); Information Retrieval (cs.IR); Machine Learning (cs.LG)
arXiv:2609.22959 [cs.AI]
(or arXiv:2609.22959v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2609.22959 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 353 words
Related coverage

Concrete Evaluations to Investigate the OpenAI Model That Hacked Hugging Face
AI Alignment Forum · Aug 3, 2026
The J-Space Debate, Agent Swarms, and Pacing Frontier AI - Digital Minds Newsletter #4
LessWrong · Sep 18, 2026

BRICS Draws a New Global Line: Full Text of New Delhi Declaration
slguardian.org · Sep 12, 2026

Digital States 2026: AI Moves From Experiment to Infrastructure
govtech.com · Sep 24, 2026